Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Polymyositis”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)WithdrawnNCT07012057
What this trial is testing

Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis

Who this might be right for
MyositisDermatomyositis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Large-scale testing (Phase 3)Active Not RecruitingNCT05523167
What this trial is testing

Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

Who this might be right for
Active Idiopathic Inflammatory MyopathyMyositisDermatomyositis+3 more
argenx 265
Testing effectiveness (Phase 2)Looking for participantsNCT07111065
What this trial is testing

FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)

Who this might be right for
Dermatomyositis (DM)Juvenile Dermatomyositis (JDM)
National Institute of Environmental Health Sciences (NIEHS) 300
Not applicableLooking for participantsNCT01276470
What this trial is testing

Environmental Risk Factors for the Anti-synthetase Syndrome

Who this might be right for
MyositisDermatomyositisPolymyositis+2 more
National Institute of Environmental Health Sciences (NIEHS) 580
Post-approval studies (Phase 4)UnknownNCT05375435
What this trial is testing

Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis

Who this might be right for
Dermatomyositis, Adult TypeInterstitial Lung Disease
The First Affiliated Hospital with Nanjing Medical University 120
Testing effectiveness (Phase 2)WithdrawnNCT02980198
What this trial is testing

Study of IFN-K in Dermatomyositis

Who this might be right for
Dermatomyositis
Neovacs
Large-scale testing (Phase 3)Study completedNCT03267277
What this trial is testing

Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis

Who this might be right for
DermatomyositisIdiopathic Inflammatory Myopathies
National Institute of Environmental Health Sciences (NIEHS) 15
Testing effectiveness (Phase 2)Study completedNCT05695950
What this trial is testing

A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

Who this might be right for
Dermatomyositis
Lakefront Biotherapeutics NV 40
Not applicableStudy completedNCT01734369
What this trial is testing

Environmental Risk Factors for Myositis in Military Personnel

Who this might be right for
DermatomyositisAdult PolymyositisInclusion Body Myositis+1 more
National Institute of Environmental Health Sciences (NIEHS) 37
Early research (Phase 1)UnknownNCT05986162
What this trial is testing

Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis

Who this might be right for
Dermatomyositis, Adult Type
Biotech Pharmaceutical Co., Ltd. 44
Not applicableUnknownNCT01482494
What this trial is testing

Detection of Pompe Disease in Adult Patients With Myopathies of Uncertain Origin or With Asymptomatic Hyper-CK-emia

Who this might be right for
Pompe Disease
Jordi Perez Lopez 50
Early research (Phase 1)Looking for participantsNCT06298019
What this trial is testing

Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis

Who this might be right for
Dermatomyositis
Stanford University 21
Early research (Phase 1)Looking for participantsNCT07085104
What this trial is testing

Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (With and Without Nephritis)Idiopathic Inflammatory MyopathySystemic Sclerosis
Allogene Therapeutics 66
Post-approval studies (Phase 4)UnknownNCT04966884
What this trial is testing

The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients

Who this might be right for
Dermatomyositis, Adult Type
First Affiliated Hospital Xi'an Jiaotong University 20
Early research (Phase 1)Looking for participantsNCT06916806
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesRheumatoid Arthritis
AstraZeneca 72
Not applicableLooking for participantsNCT07377058
What this trial is testing

RCT of Tocilizumab for Anti-MDA5+DM

Who this might be right for
Dermatomyositis
Peking Union Medical College Hospital 110
Testing effectiveness (Phase 2)Study completedNCT05669014
What this trial is testing

Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)

Who this might be right for
Idiopathic Inflammatory Myositis
Amgen 12
Not applicableLooking for participantsNCT04402086
What this trial is testing

Rheumatology Patient Registry and Biorepository

Who this might be right for
Rheumatic DiseasesAdult Onset Still DiseaseAnkylosing Spondylitis+17 more
Yale University 5,000
Large-scale testing (Phase 3)Ended earlyNCT04044690
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)

Who this might be right for
Dermatomyositis
CSL Behring 134
Testing effectiveness (Phase 2)Study completedNCT00106184
What this trial is testing

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

Who this might be right for
MyositisDermatomyositisPolymyositis+1 more
University of Pittsburgh 200
Load More Results